Trends in mortality from urologic cancers in Europe, 1970-2008
- PMID: 21497988
- DOI: 10.1016/j.eururo.2011.03.047
Trends in mortality from urologic cancers in Europe, 1970-2008
Abstract
Background: In recent decades, there have been substantial changes in mortality from urologic cancers in Europe.
Objective: To provide updated information, we analyzed trends in mortality from cancer of the prostate, testis, bladder, and kidney in Europe from 1970 to 2008.
Design, setting, and participants: We derived data for 33 European countries from the World Health Organization database.
Measurements: We computed world-standardized mortality rates and used joinpoint regression to identify significant changes in trends.
Results and limitations: Mortality from prostate cancer has leveled off since the 1990s in countries of western and northern Europe, particularly over the last few years while it was still rising in Bulgaria, Romania, and Russia. In the European Union (EU), it reached a peak in 1995 at 15.0 per 100 000 men and declined to 12.5 per 100 000 in 2006. Mortality from testicular cancer has steadily declined in most countries in western and northern Europe since the 1970s. The declines were later and appreciably lower in central/eastern Europe. In EU, rates declined from 0.75 in 1980 to 0.32 per 100 000 men in 2006, with stronger declines up to the late 1990s and an apparent leveling off in rates thereafter. Over the last 15 years, mortality from bladder cancer has declined in most European countries in both sexes. The major exceptions were Bulgaria, Poland, and Romania. In the EU, bladder cancer mortality was stable until 1992 and declined thereafter from 7.3 to 5.5 per 100 000 men and from 1.5 to 1.2 per 100 000 women in 2006. Mortality from kidney cancer increased throughout Europe until the early 1990s and leveled off thereafter in many countries, except in a few central and eastern ones. Between 1994 and 2006, rates declined from 4.9 to 4.3 per 100 000 in EU men and from 2.1 to 1.8 per 100 000 in EU women.
Conclusions: Over the last two decades, trends in urologic cancer mortality were favorable in Europe, with the exception of a few central and eastern countries.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Health care spending, social policy, public health, and life expectancy: what cancer outcomes can tell us beyond treatment efficacy.Eur Urol. 2011 Jul;60(1):16-8; discussion 19-20. doi: 10.1016/j.eururo.2011.04.004. Epub 2011 Apr 15. Eur Urol. 2011. PMID: 21501922 No abstract available.
Similar articles
-
Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe.Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):627-34. doi: 10.1177/1741826710389393. Epub 2011 Apr 26. Eur J Cardiovasc Prev Rehabil. 2011. PMID: 21521726
-
Declining mortality from bladder cancer in Europe.BJU Int. 2008 Jan;101(1):11-9. doi: 10.1111/j.1464-410X.2007.07239.x. Epub 2007 Oct 30. BJU Int. 2008. PMID: 17971176
-
Leveling of prostate cancer mortality in Western Europe.Prostate. 2004 Jun 15;60(1):46-52. doi: 10.1002/pros.20058. Prostate. 2004. PMID: 15129428
-
Gastrointestinal and liver tumours and public health in Europe.Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):259-62. Eur Rev Med Pharmacol Sci. 2010. PMID: 20496532 Review.
-
International variations and trends in renal cell carcinoma incidence and mortality.Eur Urol. 2015 Mar;67(3):519-30. doi: 10.1016/j.eururo.2014.10.002. Epub 2014 Oct 16. Eur Urol. 2015. PMID: 25449206 Review.
Cited by
-
The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.World J Urol. 2014 Apr;32(2):323-8. doi: 10.1007/s00345-012-0919-9. Epub 2012 Jul 31. World J Urol. 2014. PMID: 22847453
-
Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern.J Nephropathol. 2017 Jan;6(1):30-42. doi: 10.15171/jnp.2017.06. Epub 2016 Aug 7. J Nephropathol. 2017. PMID: 28042551 Free PMC article.
-
Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: an observational study with 30-year global data.Int J Surg. 2024 Aug 1;110(8):4633-4647. doi: 10.1097/JS9.0000000000001603. Int J Surg. 2024. PMID: 38759694 Free PMC article.
-
PDE11A gene polymorphism in testicular cancer: sperm parameters and hormonal profile.J Endocrinol Invest. 2021 Oct;44(10):2273-2284. doi: 10.1007/s40618-021-01534-3. Epub 2021 Mar 4. J Endocrinol Invest. 2021. PMID: 33661511 Free PMC article.
-
Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients.Endocrine. 2017 Sep;57(3):518-527. doi: 10.1007/s12020-016-1150-z. Epub 2016 Oct 28. Endocrine. 2017. PMID: 27796811
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources